Clinical Trial Update: Low-dose Methotrexate for Change in Global Initiative for Asthma Step 5 Medications in Chronic Severe Asthma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating low-dose methotrexate for changes in global initiative for asthma Step 5 medications in chronic severe asthma; status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Methotrexate (low-dose) (methotrexate)

Snippet

Sponsor: Universita degli Studi di Catania | Conditions: Low Dose Methotrexate in Severe Chronic Asthma | Phase 3 | Status: UNKNOWN